Drug Type Fusion protein |
Synonyms CP-deltaSOCS3, CV-08-01, CV-08-02 |
Target |
Mechanism LEPR antagonists(Leptin receptor antagonists) |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hepatocellular Carcinoma | Preclinical | KR | - | |
Obesity | Preclinical | KR | - |